Ventiv Announces Marketing Agreement With Barrier Therapeutics

Ventiv Health announced recently that they have signed a multiyear agreement with Barrier Therapeutics for a variety of services in support of a specialty dermatological sales force. Under the terms of the agreement, Ventiv will assist Barrier in marketing two of its dermatological products, Solage and Zimycan to dermatologist specialists and pediatricians across the United States.

Yahoo News (http://biz.yahoo.com/prnews/050502/nym301.html?.v=1)